Systematic review of national and international guidelines on attention-deficit hyperactivity disorder

Journal of Psychopharmacology

Volumn 26, Issue 6, 2012, Pages 753-765

  Seixas, Miguel ^a,b   Weiss, Margaret ^c   Müller, Ulrich ^a,b,d  

^a Adult ADHD Research Clinic   (United Kingdom)

^b CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; diagnosis; guidelines; therapeutics

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CLONIDINE; DEXAMPHETAMINE; GUANFACINE; LISDEXAMFETAMINE; METHYLPHENIDATE; MODAFINIL; PEMOLINE; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE TITRATION; DRUG MONITORING; HUMAN; MEDICAL HISTORY; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RATING SCALE; REVIEW; SCREENING TEST; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84862118810     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111412095     Document Type: Review

References (50)

1. Development and validation of an internal appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Qual Saf Health Care. 2003 ; 12: 18-23
2. Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000 ; 105: 1158-1170
3. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001 ; 108: 1033-1044
4. American Psychiatric Association (APA) (2000) Diagnostic and Statistical Manual of Mental Disorders version IV - text revision. Washington DC: American Psychiatric Association.
5. August G, Realmuto G. Pharmacotherapy in ADHD: Guidelines for prescribing stimulant medications in young children. Minn Med. 2000 ; 83: 45-46
6. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, et al. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry. 2006 ; 15: 476-495
7. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, et al. Langswirksame Medikamente zur Behandlung der hyperkinetischen Störungen: Eine systematische Übersicht und europäische Behandlungsleitlinien. Teil 1: Übersicht und Empfehlungen / Teil 2: Ein quantitativer Vergleich der langwirksamen Präparate. Z Kinder Jugendpsychiatr Psychotherap. 2008 ; 36: 81 97-95 107
8. Canadian ADHD Practice Guidelines. 2011 ) Canadian ADHD Practice Guidelines, Third Edition. Toronto, Ontario: CADDRA. Toronto, Ontario: CADDRA ; 2011 :
9. Cincinnati Children's Hospital Medical Center (2004) Evidence based clinical practice guideline for outpatient evaluation and management of attention deficit/hyperactivity disorder. Cincinnati, OH: Cincinnati Children's Hospital Medical Center.
10. Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. überarbeitete Auflage. Cologne: Deutscher Lrzte Verlag ; 2007 :
11. Ebert D, Krause J, Roth-Sackenheim C. ADHS im Erwachsenenalter-Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Nervenarzt. 2003 ; 74: 939-946
12. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007 ; 190: 402-409
13. Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health Survey 1999: The prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry. 2003 ; 42: 1203-1211
14. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. J Am Acad Child Adolesc Psychiatry. 2002 ; 41: 26S - 49S
15. Hayashi K, Tanaka H, Miyajima T, Saito K, Kodaira K, Yamashita Y. Advance in diagnosis and management guideline of AD/HD (attention deficit/hyperactivity disorder) for pediatricians in Japan. No to Hattatsu. 2006 ; 38: 141-143
16. Huttin C. The use of clinical guidelines to improve medical practice: Main issues in the United States. Int J Qual Health Care. 1997 ; 9: 207-214
17. Hvolby A, Jørgensen JI. Treatment with central nervous system stimulants. Practical guideline. Ugeskr Laeger. 2004 ; 166: 144-148
18. Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents. 2010 ) Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents, 8th Edition.Bloomington, Minn: Institute for Clinical Systems Improvement (ICSI). Bloomington, Minn: Institute for Clinical Systems Improvement (ICSI) ; 2010 :
19. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006 ; 163: 716-723
20. Kooij SJ, Begerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, et al. European Consensus Statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010 ; 10: 67
21. Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, et al. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol. 2004 ; 14: 11-12
22. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoact Drugs. 2006 ; 38: 43-56
23. McGough JJ Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 2005 ) Adult manifestations of attention deficit/hyperactivity disorder. In: SadockBJSadockVA (eds) Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 8th Edition. Philadelphia, PA: Lippincott Williams & Wilkins. Sadock BJ Sadock VA, ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2005 :
24. Müller U, Wolf H, Kiefer M, Gertz HJ. [A systematic comparison of national and international dementia guidelines]. Fortschr Neurol Psychiatr. 2003 ; 71: 285-295
25. NICE clinical guideline 72. London: The British Psychological Society and The Royal College of Psychiatrists ; 2008 :
26. Review of Technology Appraisal 13. London: National Institute for Health and Clinical Excellence ; 2006 :
27. Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. NIH Consens Statement Online. 1998 ; 16: 1-37
28. National Institutes of Health Consensus Development Conference Statement: Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry. 2000 ; 39: 182-193
29. New Zealand Guidelines for the Assessment and Treatment of Attention-Deficit/Hyperactivity Disorder. Wellington: Ministry of Health ; 2001 :
30. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, et al. Evidence-based guidelines for management of attention deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2006 ; 21: 10-41
31. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 ; 46: 894-921
32. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, et al. The Texas Children's Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 ; 45: 642-657
33. Pliszka SR, Lopez M, Crismon ML, Toprac MG, Hughes CW, Emslie GJ, Boemer C. A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD. J Am Acad Child Adolesc Psychiatry. 2003 ; 42: 279-287
34. Polanczyk G, De Lima MS, Horta BL, Lieberman J, Rohde LA. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry. 2007 ; 164: 942-948
35. Remschmidt H. Global consensus on ADHD/HKD. Eur Child Adolesc Psychiatry. 2005 ; 14: 127-137
36. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rössler M. [Wender Utah rating scale. The short version for the assessment of the attention-deficit hyperactivity disorder in adults]. Nervenarzt. 2002 ; 73: 830-838
37. Roy-Byrne P, Scheele L, Brinkley J, Ward N, Wiatrak C, Russo J, et al. Adult attention-deficit hyperactivity disorder: Assessment guidelines based on clinical presentation to a specialty clinic. Compr Psychiatry. 1997 ; 38: 133-140
38. Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, Otto MW. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: A randomized controlled trial. JAMA. 2010 ; 304: 875-880
39. Saito M. Diagnosis and therapeutic guideline for attention deficit hyperactivity disorder. Seishin Shinkeigaku Zasshi. 2005 ; 107: 167-179
40. Management of Attention Deficit and Hyperactivity Disorders in Children and Young People-A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN) ; 2009 :
41. Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, Kofman MD. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry. 2010 ; 167: 958-968
42. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry. 2004 ; 13: 17-30
43. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999 ; 56: 1073-1086
44. University of Michigan Health System (2005) Attention-deficit hyperactivity disorder. Ann Harbor, MI: University of Michigan Health System.
45. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993 ; 150 (6). 885-890
46. Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry. 2006 ; 45: 408-414
47. Wolraich ML, Bard DE, Stein MT, Rushton JL, O'Connor KG. Pediatricians' attitudes and practices on ADHD before and after the development of ADHD pediatric practice guidelines. J Atten Disord. 2010 ; 13: 563-572
48. Wong M, Atkins D, Taylor J, Feinleib M Diagnosis of Attention-Deficit/ Hyperactivity Disorder. Rockville, MD: Agency for Healthcare Policy and Research ; 1999 :
49. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999 ; 318: 527-530
50. World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.